This inventor holds 2 USPTO granted patents. Top assignees: Medexis S.a., P.n. Gerolymatos S.a.. Active years: 2003-2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2006
Title: Demetra Angelopoulou: Innovator in Pharmaceutical Formulations
Introduction
Demetra Angelopoulou is a notable inventor based in Ekali, Greece. She has contributed significantly to the field of pharmaceuticals, particularly in developing innovative formulations for cancer treatment. With two patents to her name, her work reflects a commitment to addressing critical health issues.
Latest Patents
Demetra's latest patents focus on pharmaceutical formulations comprising labdanes for the treatment of tumors and leukemias. The inventions involve novel compositions that incorporate hydrated lipidic lamellar phases or liposomal compositions. These formulations are prepared by combining various lipid molecules, which can be synthetic or derived from natural sources. Specifically, the compositions include labd-13-ene-8α, 15-diol and its derivatives, labd-14-ene-8, 13-diol, 3β-hydroxy-labd-14-ene-8, 13-epoxy, along with plant extracts containing these labdanes. The resulting compositions exhibit cytotoxicity against cancerous cells, offering potential therapeutic benefits for individuals battling tumors and leukemias.
Career Highlights
Throughout her career, Demetra has collaborated with various companies, including P.N. Gerolymatos S.A. and Medexis S.A. These experiences have enriched her expertise and positioned her as a prominent figure in the pharmaceutical industry.
Collaborations
Demetra has also worked alongside esteemed colleagues such as Thalia Anastassaki and Demetrios Kokkinopoulos. Their collaboration reflects a dynamic team effort towards advancing pharmaceutical innovations that can lead to improved treatment options for patients.
Conclusion
Demetra Angelopoulou continues to push the boundaries of pharmaceutical science through her innovative inventions. Her contributions, particularly in the development of labdane-based formulations for cancer treatment, showcase her dedication to improving healthcare outcomes. As she progresses in her career, her work stands as a testament to the impact that dedicated inventors can have on the lives of many.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile